Literature DB >> 16836493

The detection of human herpesvirus-8 DNA in plasma and peripheral blood mononuclear cells in adult patients with pityriasis rosea by polymerase chain reaction.

A A T Chuh1, P K S Chan, A Lee.   

Abstract

BACKGROUND: Herpesvirus-like particles have been reported to be detectable by electron microscopy in lesional biopsy of patients with pityriasis rosea (PR). We report a study investigating the association of PR with human herpesvirus-8 (HHV-8) infection.
METHODS: Our setting is a teaching clinic affiliated to a university. We recruited eight patients aged 28-47 years (mean: 34.5 years) diagnosed with PR during a one-year period. We collected acute blood specimens at presentation and convalescent blood specimens three to four weeks later. We also collected skin scrapings from the herald patch where present and from truncal secondary lesions.
RESULTS: We detected HHV-8 DNA by a nested PCR (polymerase chain reaction) targeting, respectively, a 233-bp and a 160-bp fragment of ORF 26. PCR for HHV-8 DNA was negative in the peripheral blood mononuclear cells and plasma of acute and convalescent specimens of all patients, and negative in all skin scrapings. We detected anti-HHV-8 IgG and IgM antibodies by the indirect immunofluorescence. Four patients had IgG antibodies against HHV-8, but with no significant rise of titre. None were positive for anti-HHV-8 IgM antibody.
CONCLUSION: We conclude that PR is not associated with HHV-8 infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16836493     DOI: 10.1111/j.1468-3083.2006.01569.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  Rotundiform morphology during the first episode of pityriasis versicolor - a retrospective case-control study on a distinct clinical presentation.

Authors:  Vijay Zawar; Antonio Chuh; Sudhir Sankalecha
Journal:  J Dermatol Case Rep       Date:  2007-12-29

2.  Interventions for pityriasis rosea.

Authors:  Jose Contreras-Ruiz; Sandra Peternel; Carlos Jiménez Gutiérrez; Ivana Culav-Koscak; Ludovic Reveiz; Maria de Lourdes Silbermann-Reynoso
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

3.  The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea.

Authors:  Amirhooshang Ehsani; Nafiseh Esmaily; Pedram Noormohammadpour; Siavash Toosi; Alireza Hosseinpour; Mahbobeh Hosseini; Shima Sayanjali
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

Review 4.  Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies?

Authors:  Antonio Chuh; Vijay Zawar; Gabriel F Sciallis; Werner Kempf; Albert Lee
Journal:  Infect Dis Rep       Date:  2016-03-21

Review 5.  Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria.

Authors:  Antonio Chuh; Vijay Zawar; Michelle Law; Gabriel Sciallis
Journal:  Infect Dis Rep       Date:  2012-02-15

6.  Applicability of proposed diagnostic criteria of pityriasis rosea: results of a prospective case-control study in India.

Authors:  Vijay Zawar; Antonio Chuh
Journal:  Indian J Dermatol       Date:  2013-11       Impact factor: 1.494

7.  A case series of erythema multiforme-like pityriasis rosea.

Authors:  Anupam Das; Tushar K Sarkar; Somodyuti Chandra; Anupama Ghosh; Ramesh Chandra Gharami
Journal:  Indian Dermatol Online J       Date:  2016 May-Jun

Review 8.  Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects.

Authors:  Khushbu Mahajan; Vineet Relhan; Aditi Kochhar Relhan; Vijay Kumar Garg
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.